tiprankstipranks
Trending News
More News >
Krebs Biochemicals & Industries Ltd. (IN:KREBSBIO)
:KREBSBIO
India Market

Krebs Biochemicals & Industries Ltd. (KREBSBIO) Financial Statements

Compare
0 Followers

Krebs Biochemicals & Industries Ltd. Financial Overview

Krebs Biochemicals & Industries Ltd.'s market cap is currently ₹1.61B. The company's EPS TTM is ₹-11.371; its P/E ratio is ―; Krebs Biochemicals & Industries Ltd. is scheduled to report earnings on February 18, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue₹ 504.21M₹ 521.34M₹ 529.41M₹ 386.06M₹ 235.84M
Gross Profit₹ -108.75M₹ 264.57M₹ -207.59M₹ -136.26M₹ -93.27M
Operating Income₹ -151.96M₹ -217.19M₹ -402.92M₹ -227.01M₹ -240.26M
EBITDA₹ -82.73M₹ -151.60M₹ -328.39M₹ -169.56M₹ -182.65M
Net Income₹ -197.28M₹ -246.92M₹ -445.27M₹ -283.59M₹ -288.72M
Balance Sheet
Cash & Short-Term Investments₹ 1.37M₹ 3.72M₹ 324.00K₹ 10.77M₹ 560.00K
Total Assets₹ 1.78B₹ 1.75B₹ 1.90B₹ 1.59B₹ 1.34B
Total Debt₹ 2.39B₹ 1.83B₹ 580.99M₹ 1.01B₹ 812.13M
Net Debt₹ 2.39B₹ 1.83B₹ 580.67M₹ 998.36M₹ 811.57M
Total Liabilities₹ 2.97B₹ 2.74B₹ 2.65B₹ 2.02B₹ 1.59B
Stockholders' Equity₹ -1.19B₹ -994.62M₹ -750.93M₹ -427.33M₹ -249.96M
Cash Flow
Free Cash Flow₹ -50.23M₹ -355.84M₹ -407.36M₹ -400.81M₹ -452.74M
Operating Cash Flow₹ 23.04M₹ -247.13M₹ -172.16M₹ -145.75M₹ -358.63M
Investing Cash Flow₹ -78.17M₹ -126.45M₹ -229.00M₹ -225.49M₹ -90.46M
Financing Cash Flow₹ 55.64M₹ 373.43M₹ 395.06M₹ 376.61M₹ 277.64M
Currency in INR

Krebs Biochemicals & Industries Ltd. Earnings and Revenue History

Krebs Biochemicals & Industries Ltd. Debt to Assets

Krebs Biochemicals & Industries Ltd. Cash Flow

Krebs Biochemicals & Industries Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis